Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression.

The British journal of dermatology - 1 Jan 2013

Reid A L, Millward M, Pearce R, Lee M, Frank M H, Ireland A, Monshizadeh L, Rai T, Heenan P, Medic S, Kumarasinghe P, Ziman M

Abstract excerpt

BACKGROUND: Multimarker quantitative real-time polymerase chain reaction (qRT-PCR) represents an effective method for detecting circulating tumour cells in the peripheral blood of patients with melanoma. OBJECTIVES: To investigate whether the phenotype of circulating melanoma cells represents a u...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Melanoma
Share to Neoplasm Recurrence, Local

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplastic Cells, Circulating

Share to Real-Time Polymerase Chain Reaction

Share to Skin Neoplasms

Share to Treatment Outcome

Share to Tumor Burden

Source

Open in PubMed Open full text

Identifiers

PMID: 23013138
DOI: 10.1111/bjd.12057
PMCID: PMC3538032

Genes

ABCB5
MLANA
MCAM

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23013138-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression.PMID 23013138Read ↗

Molecular markers of circulating melanoma cells.Semantic proximity Read ↗

Serum‐based miRNAs in the prediction and detection of recurrence in melanoma patientsSemantic proximity Read ↗

Circulating Tumor DNA: A Promising Biomarker for Predicting Recurrence in Patients with BRAF-Negative Melanoma.Semantic proximity Read ↗

Circulating cell-free messenger RNA enables non-invasive pan-tumour monitoring of melanoma therapy independent of the mutational genotype.Semantic proximity Read ↗

Immunomagnetic-Enriched Subpopulations of Melanoma Circulating Tumour Cells (CTCs) Exhibit Distinct Transcriptome ProfilesSemantic proximity Read ↗

Detection and prognostic role of heterogeneous populations of melanoma circulating tumour cellsSemantic proximity Read ↗

Sequential molecular analysis of circulating MCAM/MUC18 expression: a promising disease biomarker related to clinical outcome in melanomaSemantic proximity Read ↗

Analysis of uveal melanoma scRNA sequencing data identifies neoplastic-immune hybrid cells that exhibit metastatic potentialSemantic proximity Read ↗

Melanoma MicroRNA Signature Predicts Post-Recurrence SurvivalSemantic proximity Read ↗

The Circulating Transcriptome as a Source of Biomarkers for MelanomaSemantic proximity Read ↗

Feasibility of personalized circulating tumor DNA detection in stage II and III melanoma.Semantic proximity Read ↗

Comprehensive characterization of circulating tumor cells and cell-free DNA in patients with metastatic melanoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.